InvestorsHub Logo
Followers 47
Posts 12040
Boards Moderated 0
Alias Born 09/12/2017

Re: misiu143 post# 224871

Friday, 09/22/2023 10:17:30 AM

Friday, September 22, 2023 10:17:30 AM

Post# of 233004
So 82% in leronlimab CD12 study , 82% in mortality benefit ABOVE any other drug in a dying , critical patients was not even looked at..

So you continue to engage in fraud by yodeling the 82% nonsense correct?---

“Moreover, Pourhassan was aware he was engaging in fraud because he was repeatedly told by many, including the FDA, that his statements to investors were false and misleading — and he nevertheless continued in a relentless campaign of lies to raise millions of dollars and make himself rich by illegally selling company stock based on material, nonpublic information," the government's brief says.



FDA said- "None of these analyses met statistical significance when using established and reliable analytical methods that correct for multiple comparisons."
https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News